These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7470791)

  • 1. Iodine 131 ablation therapy for a patient on maintenance haemodialysis.
    Howard N; Glasser M
    Br J Radiol; 1981 Mar; 54(639):259. PubMed ID: 7470791
    [No Abstract]   [Full Text] [Related]  

  • 2. 131I treatment of thyroid papillary carcinoma in a patient with renal failure.
    Morrish DW; Filipow LJ; McEwan AJ; Schmidt R; Murland KR; von Westarp C; Betcher KB
    Cancer; 1990 Dec; 66(12):2509-13. PubMed ID: 2249192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodine treatment of thyroid carcinoma in patients on maintenance hemodialysis.
    Daumerie C; Vynckier S; Caussin J; Jadoul M; Squifflet JP; de Patoul N; Wambersie A
    Thyroid; 1996 Aug; 6(4):301-4. PubMed ID: 8875750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine-131 treatment of thyroid papillary carcinoma in patients undergoing dialysis for chronic renal failure: a dosimetric method.
    Jiménez RG; Moreno AS; Gonzalez EN; Simón FJL ; Rodriguez JR; Jimenez JC; Córdoba MH; Albertino RV; Jimenez RA
    Thyroid; 2001 Nov; 11(11):1031-4. PubMed ID: 11762712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (131)I treatment in Differentiated Thyroid Cancer and End-Stage Renal Disease.
    Ortega AJ; Vázquez RG; Cuenca JI; Brocca MA; Castilla J; Martínez JM; González EN
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):29-33. PubMed ID: 26144699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of radioactive iodine I-131 and monitoring of radioactivity in patients with chronic kidney disease on haemodialysis.
    Gallegos-Villalobos A; García-López F; Escalada C; Ortiz JJ; Cardona J; Medina A; Portolés J
    Nefrologia; 2014 May; 34(3):317-22. PubMed ID: 24798564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of thyroid papillary carcinoma with radioiodine in a patient with end stage renal disease on hemodialysis.
    Mello AM; Isaacs R; Petersen J; Kronenberger S; McDougall IR
    Clin Nucl Med; 1994 Sep; 19(9):776-81. PubMed ID: 7982310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment with (131)I of thyroid remnants in a patient with papillary thyroid carcinoma and end-stage chronic renal failure].
    Andres A; Tardín L; Santapau A; Razola P; Prats E; Parra A; Rivas MA; Ruiz P; Alvarez R; Camara A; Banzo J
    Rev Esp Med Nucl; 2010; 29(1):32-5. PubMed ID: 20018412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation safety protocol for high dose 131I therapy of thyroid carcinoma in patients on hemodialysis for chronic renal failure.
    Modarresifar H; Almodovar S; Bass WB; Ojha B
    Health Phys; 2007 Feb; 92(2 Suppl):S45-9. PubMed ID: 17228187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Necessity to administer 131I in a patient with papillary thyroid carcinoma undergoing chronic hemodialysis].
    Novik V; González R; Díaz M; Vega J
    Rev Med Chil; 1998 Jul; 126(7):874-5. PubMed ID: 9830782
    [No Abstract]   [Full Text] [Related]  

  • 11. The management of well-differentiated thyroid cancer with end-stage renal disease.
    Wang TH; Lee CH; Tseng LM; Liu RH
    Endocrine; 2003 Aug; 21(3):227-31. PubMed ID: 14515006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis of chronic kidney failure patients requiring ablative radioiodine therapy.
    Murcutt G; Edwards J; Boakye J; Davenport A
    Kidney Int; 2008 Jun; 73(11):1316-9. PubMed ID: 18354377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A glowing report on dialysis.
    Stabroth C; Luft FC
    Nephrol Dial Transplant; 2005 May; 20(5):1005-6. PubMed ID: 15831551
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of hemodialysis on iodine-131 biokinetics in thyroid carcinoma patients with end-stage chronic renal failure.
    Yeyin N; Cavdar I; Uslu L; Abuqbeitah M; Demir M
    Nucl Med Commun; 2016 Mar; 37(3):283-7. PubMed ID: 26619394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioactive 131I use in end-stage renal disease: nightmare or nuisance?
    Sinsakul M; Ali A
    Semin Dial; 2004; 17(1):53-6. PubMed ID: 14717812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioactive iodine in the treatment of thyroid carcinoma].
    Pendić S; Tasić S
    Srp Arh Celok Lek; 1980 Oct; 108(10):1021-9. PubMed ID: 7292160
    [No Abstract]   [Full Text] [Related]  

  • 17. Commentary: Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.
    Terris DJ
    Head Neck; 2010 Jun; 32(6):698-9. PubMed ID: 20187017
    [No Abstract]   [Full Text] [Related]  

  • 18. Should radioactive iodine therapy be administrated in patient of papillary thyroid carcinoma?
    Zhao J; Dong J; Sun Q; Wang H; Zhang Z; Zhou X; Liao L
    Chin Med J (Engl); 2014; 127(16):3039-40. PubMed ID: 25131255
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor thrombus in the great veins from papillary carcinoma of the thyroid: 131I scan findings.
    Mugunthan N; Kumar AR; Thomas P
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2527-8. PubMed ID: 20525903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vocal cord paralysis following I-131 ablation of a postthyroidectomy remnant.
    Lee TC; Harbert JC; Dejter SW; Mariner DR; VanDam J
    J Nucl Med; 1985 Jan; 26(1):49-50. PubMed ID: 3965651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.